Although we have conducted in-depth research on the immune escape landscape and molecular mechanisms of MINDY1 in liver cancer, there are significant differences in the biological mechanisms and frequencies related to immune escape among different cancer types, which increases the complexity of the study and limits the widespread application of our research results. This evidence concerns the gene MINDY1 and liver cancer.